HYDRALAZINE Side Effects

5530406-9 | Pericardial Effusion, Systemic Lupus Erythematosus
on Nov 27, 2007 Male patient from UNITED STATES , 57 years of age, was diagnosed with hypertension and was treated with Hydralazine (View Usage). Patient experienced the following unwanted or unexpected effects: pericardial effusion, systemic lupus erythematosus. Hydralazine dosage: 100mg Tid Po. Patient was hospitalized.

5088306-7 | Lupus Pneumonitis
Patient was taking Hydralazine (View Usage). Patient had the following side effects: lupus pneumonitis on Aug 10, 2006 from UNITED STATES Additional patient health information: Female patient , 36 years of age, was diagnosed with hypertension and. Hydralazine dosage: 100 Mg, Daily, Oral. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ). Patient was hospitalized.

4993416-6 | Bone Disorder, Cerebral Ischaemia, Exostosis, Extrapyramidal Disorder, Gait Disturbance, Memory Impairment
Adverse event was reported on Apr 25, 2006 by a Female patient taking Hydralazine (View Usage) (Dosage: ) . Location: UNITED STATES , 85 years of age, After Hydralazine was administered, patient had the following side effects: bone disorder, cerebral ischaemia, exostosis, extrapyramidal disorder, gait disturbance, memory impairment. During the same period patient was treated with DILTIAZEM (View Diltiazem Review and Diltiazem Label ), SERTRALINE (View Sertraline Review and Sertraline Label ).

4892678-3 | Asthma, Blood Pressure Increased, Extracorporeal Membrane Oxygenation, Hyperhidrosis, Respiratory Distress
on Jan 25, 2006 Male patient from UNITED STATES , 33 years of age, weighting 143.3 lb, was diagnosed with hypertension and was treated with Hydralazine (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), blood pressure increased, extracorporeal membrane oxygenation, hyperhidrosis, respiratory distress. Hydralazine dosage: 20mg Iv X 1. Patient was hospitalized.


4887889-7 | Anaemia, Anaemia Of Chronic Disease, Arthralgia, Asthenia, Back Pain, Bursitis, Carotid Artery Stenosis, Cellulitis, Dizziness
on Dec 23, 2005 Male patient from UNITED STATES , 61 years of age, was treated with Hydralazine (View Usage). Patient had the following side effects: anaemia, anaemia of chronic disease, arthralgia, asthenia, back pain (What is back pain?), bursitis (What is bursitis?), carotid artery stenosis, cellulitis (What is cellulitis?), dizziness (What is dizziness?). Hydralazine dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), MAGNESIUM CHLORIDE (View Magnesium Chloride Review and Magnesium Chloride Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), TERAZOSIN HYDROCHLORIDE (View Terazosin Hydrochloride Review and Terazosin Hydrochloride Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

4761732-9 | Aortic Valve Sclerosis, Asthenia, Blood Pressure Decreased, Cardiomyopathy, Cerebral Atherosclerosis, Cerebral Ischaemia, Coronary Artery Disease, Dizziness, Electrocardiogram St Segment Depression
Patient was taking Hydralazine (View Usage). After Hydralazine was administered, patient had the following side effects: aortic valve sclerosis, asthenia, blood pressure decreased, cardiomyopathy (What is cardiomyopathy?), cerebral atherosclerosis, cerebral ischaemia, coronary artery disease (What is coronary artery disease?), dizziness (What is dizziness?), electrocardiogram st segment depression on Apr 20, 2005 from UNITED STATES Additional patient health information: Female patient , 57 years of age, . Hydralazine dosage: 10 Mg Ivp. During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), EQUAGESIC (View Equagesic Review and Equagesic Label ), IRON (View Iron Review and Iron Label ), LASIX (View Lasix Review and Lasix Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), ATARAX (View Atarax Review and Atarax Label ), ALLEGRA (View Allegra Review and Allegra Label ). Patient was hospitalized.

4761729-9 | Aortic Valve Sclerosis, Asthenia, Blood Pressure Decreased, Cardiomegaly, Cardiomyopathy, Cerebral Atherosclerosis, Cerebral Ischaemia, Computerised Tomogram Abnormal, Coronary Artery Disease
Adverse event was reported on Apr 20, 2005 by a Female patient taking Hydralazine (View Usage) (Dosage: 10 Mg Ivp) . Location: UNITED STATES , 57 years of age, Patient experienced the following unwanted or unexpected effects: aortic valve sclerosis, asthenia, blood pressure decreased, cardiomegaly, cardiomyopathy (What is cardiomyopathy?), cerebral atherosclerosis, cerebral ischaemia, computerised tomogram abnormal, coronary artery disease (What is coronary artery disease?). During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), EQUAGESIC (View Equagesic Review and Equagesic Label ), IRON (View Iron Review and Iron Label ), LASIX (View Lasix Review and Lasix Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), ATARAX (View Atarax Review and Atarax Label ), ALLEGRA (View Allegra Review and Allegra Label ). Patient was hospitalized.

4761721-4 | Aortic Valve Sclerosis, Asthenia, Blood Pressure Decreased, Cardiomegaly, Cardiomyopathy, Cerebral Atherosclerosis, Cerebral Ischaemia, Coronary Artery Disease, Dizziness
on Apr 20, 2005 Female patient from UNITED STATES , 57 years of age, was treated with Hydralazine (View Usage). Patient had the following side effects: aortic valve sclerosis, asthenia, blood pressure decreased, cardiomegaly, cardiomyopathy (What is cardiomyopathy?), cerebral atherosclerosis, cerebral ischaemia, coronary artery disease (What is coronary artery disease?), dizziness (What is dizziness?). Hydralazine dosage: 10 Mg Ivp. During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), EQUAGESIC (View Equagesic Review and Equagesic Label ), IRON (View Iron Review and Iron Label ), LASIX (View Lasix Review and Lasix Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), ATARAX (View Atarax Review and Atarax Label ), ALLEGRA (View Allegra Review and Allegra Label ). Patient was hospitalized.

4736458-8 | Caesarean Section, Cervical Incompetence, Hypertension
on Jul 27, 2005 Female patient from UNITED STATES , 33 years of age, was diagnosed with hypertension and was treated with Hydralazine (View Usage). After Hydralazine was administered, patient had the following side effects: caesarean section, cervical incompetence, hypertension. Hydralazine dosage: . During the same period patient was treated with NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), LABETALOL (View Labetalol Review and Labetalol Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), IRON (View Iron Review and Iron Label ), CALCITRIOL (View Calcitriol Review and Calcitriol Label ).